Exploring Biomarkers in Congenital Heart Disease: A Case–Control Study of ST2 in Children with Atrial Septal Defects
Open Access
- 12 April 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3445
Abstract
Soluble growth stimulation protein form of interleukin-1 receptor-like 1 (ST2) may signal myocardial stress, and elevated ST2 blood levels are associated with adverse outcomes in adult heart disease. Data on ST2 in children with congenital heart disease (CHD) is limited. This study explored ST2 in newborns and older children with atrial septal defect (ASD), as this represents a common CHD type that remains clinically challenging to recognize in childhood with slowly evolving symptoms. A case–control study was carried out in newborn ASD cases versus controls measuring ST2 on dried blood spot samples and additionally in pediatric ASD cases versus controls on venous blood together with cardiac magnetic resonance before and after treatment. ST2 was higher in newborns with ASD (n = 19) compared to controls (n = 93); (p < 0.01). Receiver operating characteristics to diagnose newborn ASD by ST2 showed an area under the curve of 0.848. Levels of ST2 decreased in pediatric ASD (n = 16) after treatment (p = 0.014). Lower left ventricular ejection fraction correlated with higher ST2 levels before (r = −0.348) and after treatment (r = −0.497). Elevated ST2 in newborns may aid early ASD diagnosis. Levels of ST2 in pediatric ASD decrease after treatment, and higher levels are associated with lower left ventricular ejection fraction, warranting further study.Keywords
Funding Information
- Regional Health Service at Skane University Hospital (2025-2749)
- Regional Health Service at Skane University Hospital (2022-0288)
- Hjärt-Lungfonden (20241381)
- Hjärt-Lungfonden (20240935)
- Hjärt-Lungfonden (20240862)
- Hjärt-Lungfonden (20220737)
- Hjärt-Lungfonden (20220369)
- Hjärt-Lungfonden (20210399)
- Svenska Läkaresällskapet (100611)
- Vetenskapsrådet (202202757)
This publication has 76 references indexed in Scilit:
- Left Ventricular Diastolic Function in Children with Atrial Septal Defects Improves After Closure by Means of Increased Hydraulic ForcePediatric Cardiology, 2024
- Newborn Screening for High-Risk Congenital Heart Disease by Dried Blood Spot Biomarker AnalysisJAMA Network Open, 2024
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of CardiologyEuropean Journal of Heart Failure, 2022
- Circulating Levels and Prognostic Cut-Offs of sST2, hs-cTnT, and NT-proBNP in Women vs. Men with Chronic Heart FailureESC Heart Failure, 2022
- Circulating Levels and Prognostic Value of Soluble ST2 in Heart Failure are Less Influenced by Age than N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Troponin TEuropean Journal of Heart Failure, 2020
- The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the MyocardiumJournal of Cardiovascular Translational Research, 2017
- ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus PanelThe American Journal of Cardiology, 2015
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Assessment of right ventricular function by three-dimensional echocardiography and myocardial strain imaging in adult atrial septal defect before and after percutaneous closureThe International Journal of Cardiovascular Imaging, 2012
- Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection FractionThe American Journal of Cardiology, 2011